SCHEMBL12825525

SCHEMBL12825525

NCCC(C(=O)Nc1ccc2[nH]nc(Nc3cccc(-c4ccccc4)c3)c2c1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.56
▸ CDK2 P24941 3/20 0.56
▸ ROCK2 O75116 2/20 0.56
▸ CDC7 O00311 1/20 0.56
▸ PLK4 O00444 1/20 0.56
▸ CHEK1 O14757 1/20 0.56
▸ DCLK1 O15075 1/20 0.56
▸ MAPK13 O15264 1/20 0.56
▸ PDPK1 O15530 1/20 0.56
▸ DAPK3 O43293 1/20 0.56
▸ DYRK3 O43781 1/20 0.56
▸ RPS6KA5 O75582 1/20 0.56
▸ PRKD3 O94806 1/20 0.56
▸ MAP4K4 O95819 1/20 0.56
▸ PAK4 O96013 1/20 0.56
▸ CHEK2 O96017 1/20 0.56
▸ PRKCG P05129 1/20 0.56
▸ FYN P06241 1/20 0.56
▸ CDK1 P06493 1/20 0.56
▸ ROS1 P08922 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12825860 0.89 ROCK2 (0.57) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825861 0.89 ROCK2 (0.57) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825405 0.88 AURKB (0.60) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825523 0.87 AURKB (0.55) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12826062 0.86 AURKB (0.64) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825386 0.85 CDK2 (0.60) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825312 0.85 CDK2 (0.60) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825311 0.83 ROCK2 (0.53) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12824519 0.83 DYRK1A (0.64) GSK3BCDK2ROCK2CDC7PLK4
SCHEMBL12825511 0.82 MAPK1 (0.61) GSK3BCDK2ROCK2CDC7PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295413-A1 Indazole compounds useful as protein kinase inhibitors Vertex Pharmaceuticals Incorporated (US) 2011-03-16 — — EP disclosed
Send feedback